Web Exclusives

FDA expands use of Xalkori

On March 11, the Food and Drug Administration (FDA) approved Xalkori (crizotinib) to treat people with metastatic non-small cell lung cancer (NSCLC) whose tumors…

Flu vaccine nearly 60% effective

On Feb. 24, the Centers for Disease Control and Prevention reported preliminary overall influenza vaccine effectiveness of 59% this season. Read more.

Zika Virus resources from CDC

The Centers for Disease Control and Prevention (CDC) has established a Zika Virus resource section. Access the section.

FDA expands use of Xalkori

On March 11, the Food and Drug Administration (FDA) approved Xalkori (crizotinib) to treat people with metastatic non-small cell lung cancer (NSCLC)…

Flu vaccine nearly 60% effective

On Feb. 24, the Centers for Disease Control and Prevention reported preliminary overall influenza vaccine effectiveness of 59% this season. Read more.

Zika Virus resources from CDC

The Centers for Disease Control and Prevention (CDC) has established a Zika Virus resource section. Access the section.

Poll

Preferred way to get content

What is your preferred way to consume healthcare content?

cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • This field is hidden when viewing the form

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.